{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:51Z","timestamp":1793317911493,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1093\/annonc\/mdh095","type":"journal-article","created":{"date-parts":[[2004,3,3]],"date-time":"2004-03-03T14:13:19Z","timestamp":1078323199000},"page":"460-466","source":"Crossref","is-referenced-by-count":902,"title":["Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"L.","family":"Rubbia-Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sartoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brezault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Le Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Soubrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mentha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Terris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh095_bb0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh095_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000658-200004000-00006","article-title":"Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results","volume":"231","author":"Minagawa","year":"2000","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdh095_bb0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1011126028604","article-title":"Surgical management of hepatic metastases from colorectal malignancies","volume":"12","author":"Malafosse","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1008347829017","article-title":"Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery","volume":"10","author":"Giacchetti","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0030","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdh095_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1040-8428(01)00192-5","article-title":"Oxaliplatin: results in colorectal carcinoma","volume":"44","author":"Carrato","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdh095_bb0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh095_bb0045","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh095_bb0050","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2002.08.015","article-title":"Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial","volume":"20","author":"Souglakos","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2000.18.1.136","article-title":"Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil\u2013leucovorin as first-line treatment of metastatic colorectal cancer","volume":"18","author":"Giacchetti","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/sonc.2002.35531","article-title":"The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions","volume":"29","author":"Schmoll","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0065","first-page":"40","article-title":"Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy","volume":"25","author":"Bismuth","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00000478-199311000-00008","article-title":"Nodular regenerative hyperplasia in partial hepatectomy specimens","volume":"17","author":"Washington","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdh095_bb0075","first-page":"524","article-title":"Hepatic arterial chemotherapy in metastatic colorectal patients","volume":"26","author":"Kemeny","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0080","first-page":"561","article-title":"The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits","volume":"9","author":"Cwikiel","year":"1995","journal-title":"Scanning Microsc"},{"key":"10.1093\/annonc\/mdh095_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1093\/annonc\/mdh095_bb0090","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdh095_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-1755.2000.00808.x","article-title":"Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells","volume":"57","author":"Eberhardt","year":"2000","journal-title":"Kidney Int"},{"key":"10.1093\/annonc\/mdh095_bb0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/labinvest.3780456","article-title":"Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts","volume":"82","author":"Uchio","year":"2002","journal-title":"Lab Invest"},{"key":"10.1093\/annonc\/mdh095_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.1999.00569.x","article-title":"Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation","volume":"34","author":"Sato","year":"1999","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdh095_bb0110","first-page":"211","article-title":"Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats","volume":"74","author":"Yeong","year":"1993","journal-title":"Int J Exp Pathol"},{"key":"10.1093\/annonc\/mdh095_bb0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdh095_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.510260214","article-title":"Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver","volume":"26","author":"Shimamatsu","year":"1997","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdh095_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1040-8428(00)00070-6","article-title":"Oxaliplatin clinical activity: a review","volume":"35","author":"Misset","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdh095_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.35524","article-title":"Oxaliplatin-related side effects: characteristics and management","volume":"29","author":"Cassidy","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0135","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh095_bb0140","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1200\/JCO.2002.07.061","article-title":"Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Cascinu","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh095_bb0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdh095_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology"},{"key":"10.1093\/annonc\/mdh095_bb0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.510310224","article-title":"Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat","volume":"31","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdh095_bb0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/jhep.2003.50063","article-title":"The nitric oxide donor, V-PYRRO\/NO, protects against acetaminophen-induced hepatotoxicity in mice","volume":"37","author":"Liu","year":"2003","journal-title":"Hepatology"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/3\/460\/558038\/mdh095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T21:15:25Z","timestamp":1582233325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419641426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0923753419641426"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh095","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}